共 63 条
[1]
Maccioni F(2010)Magnetic resonance cholangiography: past, present and future: a review Eur Rev Med Pharmacol Sci 14 721-725
[2]
Martinelli M(2019)Clinical usefulness of gadoxetic acid–enhanced MRI for evaluating biliary anatomy in living donor liver transplantation Eur Radiol 29 6508-6518
[3]
Al Ansari N(2021)Consensus report from the 9th international forum for liver magnetic resonance Imaging: applications of gadoxetic acid-enhanced imaging Eur Radiol 31 5615-5628
[4]
Choi SH(2020)Quantification of liver function using gadoxetic acid-enhanced MRI Abdom Radiol (NY) 45 3532-3544
[5]
Kim KW(2012)Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine Eur J Radiol 81 2037-2041
[6]
Kwon HJ(2010)Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine J Magn Reson Imaging 31 356-364
[7]
Koh DM(2018)Dechelation (Transmetalation): consequences and safety concerns with the linear gadolinium-based contrast agents, in view of recent health care rulings by the EMA (Europe), FDA (United States), and PMDA (Japan) Invest Radiol 53 571-578
[8]
Ba-Ssalamah A(2012)Primovist, Eovist: what to expect? J Hepatol 57 421-429
[9]
Brancatelli G(2021)(2021) Gadobenate dimeglumine–enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis Eur Radiol 318 5840-5850
[10]
Poetter-Lang S(2021)(2022) Gd-BOPTA-enhanced hepatobiliary phase MR imaging can predict the prognosis of patients with acute-on-chronic liver failure Eur Radiol 325 3006-3015